1-2 of 2
Keywords: Na+-K+-ATPase
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Articles

Regulation of Na + -K + -ATPase leads to disturbances of isoproterenol-induced cardiac dysfunction via interference of Ca 2+ -dependent cardiac metabolism

Xiaofei Yan, Meihe Li, Ping Lan, Meng Xun, Ying Zhang, Jinghui Shi, Ruijia Wang, Jin Zheng
Journal: Clinical Science
Clin Sci (Lond) (2024) 138 (1): 23–42.
https://doi.org/10.1042/CS20231039
Published: 05 January 2024
...Xiaofei Yan; Meihe Li; Ping Lan; Meng Xun; Ying Zhang; Jinghui Shi; Ruijia Wang; Jin Zheng Reductions in Na + -K + -ATPase (NKA) activity and expression are often observed in the progress of various reason-induced heart failure (HF). However, NKA α1 mutation or knockdown cannot cause spontaneous...
View articletitled, Regulation of Na + -K + -ATPase leads to disturbances of isoproterenol-induced cardiac dysfunction via interference of Ca 2+ -dependent cardiac metabolism
Open the PDF for Regulation of Na + -K + -ATPase leads to disturbances of isoproterenol-induced cardiac dysfunction via interference of Ca 2+ -dependent cardiac metabolism in another window
Includes: Supplementary data
Articles

Effect of Oral Digoxin, Topical Ouabain and Salbutamol on Transepithelial Nasal Potential Difference in Patients with Cystic Fibrosis

D. G. Peckham, A. Conn, C. Chotai, S. Lewis, A. J. Knox
Journal: Clinical Science
Clin Sci (Lond) (1995) 89 (3): 277–284.
https://doi.org/10.1042/cs0890277
Published: 01 September 1995
... + -ATPase inhibitor, and in cystic fibrosis patients the number and activity of nasal epithelial Na + -K + -ATPase pumps is increased. 2. We have performed a series of studies to determine whether drugs which modify airway epithelial Na + -K + -ATPase activity in vitro can modify nasal potential in cystic...
View articletitled, Effect of Oral Digoxin, Topical Ouabain and Salbutamol on Transepithelial Nasal Potential Difference in Patients with Cystic Fibrosis
Open the PDF for Effect of Oral Digoxin, Topical Ouabain and Salbutamol on Transepithelial Nasal Potential Difference in Patients with Cystic Fibrosis in another window